David Krummenacher is an Investor at Roche, whose known portfolio counts 14 companies.
Is David Krummenacher a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
Investor at Roche, whose known portfolio counts 14 companies
- Freenome
- C4 Therapeutics
- Splice Bio
- GlycoEra
- Flatiron Health
- MISSION Therapeutics
- NMD Pharma
- Cour Pharmaceuticals Development
- Proacta
- Affimed
- DiogenX
- Mironid
- and 2 more
Investor Profile
Founders in the listed sectors AI and Healthcare, and focus areas Biotech, Data Analytics, Diagnostics and Digital Health fall inside that listing.
Roche appears in Growth, Late-Stage and Pre-Seed rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether David Krummenacher is worth approaching.
Colleagues at Roche
Deborah Weyih
Investor
Rodersdorf, Switzerland
Ouali Omani
Global Commercialisation Strategy Leader
Basel, Switzerland
Muriel Badawi
Affiliated
Paris, France
David Evans
Senior Investment Director
Basel, Switzerland
Ursula Erasmus
Investor
Canada
Cedric Mauchien
Investor
Zürich, Switzerland
Carole Nuechterlein
Investor
Basel, Switzerland
Jacques Mizrahi
Executive Leader, Cardiovascular & Metabolic Diseases
Basel, Switzerland
Frequently asked questions
Who is David Krummenacher?
David Krummenacher is a corporate venture investor based in Lucerne, Switzerland, listed as Investor at Roche. The known portfolio of that firm counts 14 companies. That portfolio belongs to the firm, not to David Krummenacher personally.
What does David Krummenacher invest in?
Listed sectors include AI and Healthcare; listed focus areas include Biotech, Data Analytics, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does David Krummenacher invest at?
Roche appears in Growth, Late-Stage and Pre-Seed rounds across its known deals, and David Krummenacher is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is David Krummenacher listed at?
David Krummenacher is listed as Investor at Roche. 8 other people in the database share a firm with David Krummenacher.
How do I contact David Krummenacher?
A LinkedIn page is on file for David Krummenacher. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal